Stay updated on CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial
Sign up to get notified when there's something new on the CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial page.

Latest updates to the CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial page
- Check3 days agoChange DetectedDifference0.4%

- Check10 days agoChange DetectedGlossary display was added. The page metadata was updated with new QC-related timestamps and No FEAR Act data text, replacing older entries.SummaryDifference0.4%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page now displays a revision update: Revision: v3.3.4 replaces Revision: v3.3.3. This appears to be a site maintenance/versioning change with no impact on the study details, eligibility criteria, or results presented. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check46 days agoChange DetectedAdded a Locations section with Missouri as a study site; removed the HHS Vulnerability Disclosure link.SummaryDifference0.2%

- Check74 days agoChange DetectedThe revisions metadata now shows v3.3.2 instead of v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check81 days agoChange DetectedThe government funding/operating status disclaimer was removed from the page.SummaryDifference0.3%

Stay in the know with updates to CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial page.